Regarding “Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies”
Oncologist - United States
doi 10.1634/theoncologist.2017-0202
Full Text
Open PDFAbstract
Available in full text
Date
June 2, 2017
Authors
Publisher
Alphamed Press